For more than 30 years, Texcell provides comprehensive, standard protocols for evaluating your cell banks, raw materials and cell derivatives such as monoclonal antibodies, recombinant proteins, vaccines and gene therapy products.

To ensure the safety of your biotherapeutic product, Texcell offers a vast array of services and tests. Every study is designed in accordance with the EU or US Pharmacopoeia and EMEA or FDA guidelines. All studies are performed in accordance to GLP-guidelines, or detailed SOPs can be provided for GMP-standard assays for batch release testing.

Our catalogue contains more than 200 technical procedures to ensure that all viral contaminants are absent from your biotherapeutic. Texcell’s teams assist you from the R&D until the marketing authorization.

Please check-out the different pages by product.

Keep note that Texcell also provides services for blood derivated products and medical devices.